1. |
Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J, 1990, 265(3): 621-636.
|
2. |
徐彬, 裴福兴. 髋膝关节置换术加速康复中糖皮质激素的作用. 中华骨与关节外科杂志, 2017, 10(3): 259-264.
|
3. |
Kugisaki H, Sonohata M, Komine M, et al. Serum concentrations of interleukin-6 in patients following unilateral versus bilateral total knee arthroplasty. J Orthop Sci, 2009, 14(4): 437-442.
|
4. |
Xie JW, Ma J, Yao H, et al. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: A Randomized Clinical Trial. J Arthroplasty, 2016, 31(11): 2458-2464.
|
5. |
Eroğlu M, Kokulu S, Koca HB, et al. The effects of general and spinal anesthesia on systemic inflammatory response in patients undergoing total knee arthroplasty. Eklem Hastalik Cerrahisi, 2016, 27(3): 153-159.
|
6. |
Tsunoda K, Sonohata M, Kugisaki H, et al. The effect of air tourniquet on interleukin-6 levels in total knee arthroplasty. Open Orthop J, 2017, 11: 20-28.
|
7. |
Xu B, Ma J, Huang Q, et al. Two doses of low-dose perioperative dexamethasone improve the clinical outcome after total knee arthroplasty: a randomized controlled study. Knee Surg Sports Traumatol Arthrosc, 2018, 26(5): 1549-1556.
|
8. |
Yue C, Wei R, Liu Y. Perioperative systemic steroid for rapid recovery in total knee and hip arthroplasty: a systematic review and meta-analysis of randomized trials. J Orthop Surg Res, 2017, 12(1): 100.
|
9. |
Lunn TH, Kehlet H. Perioperative glucocorticoids in hip and knee surgery-benefit vs. harm? A review of randomized clinical trials. Acta Anaesthesiol Scand, 2013, 57(7): 823-834.
|
10. |
Wegener JT, Kraal T, Stevens MF, et al. Low-dose dexamethasone during arthroplasty: What do we know about the risks? EFORT Open Rev, 2016, 1(8): 303-309.
|
11. |
Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg (Am), 2012, 94(13): 1153-1159.
|
12. |
Busuttil SJ, Ploplis VA, Castellino FJ, et al. A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost, 2004, 2(10): 1798-1805.
|
13. |
Jimenez JJ, Iribarren JL, Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care, 2007, 11(6): R117.
|
14. |
Lei YT, Xie JW, Xu B, et al. The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial. Int Orthop, 2017, 41(10): 2053-2059.
|
15. |
Bin Abd Razak HR, Han XA, Chong HC, et al. Total knee arthroplasty in Asian subjects: preoperative range of motion determines postoperative range of motion? Orthop Surg, 2014, 6(1): 33-37.
|
16. |
Farahini H, Moghtadaei M, Bagheri A, et al. Factors influencing range of motion after total knee arthroplasty. Iran Red Crescent Med J, 2012, 14(7): 417-421.
|
17. |
孙仁刚, 杨黄. 高血压病患者手术应激反应的年龄差异. 医学文选, 2000, 19(2): 130-132.
|
18. |
Kotake S, Sato K, Kim KJ, et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res, 1996, 11(1): 88-95.
|
19. |
Lisowska B, Maslinski W, Maldyk P, et al. The role of cytokines in inflammatory response after total knee arthroplasty in patients with rheumatoid arthritis. Rheumatol Int, 2008, 28(7): 667-671.
|
20. |
Huang ZY, Shen B, Ma J, et al. Mini-midvastus versus medial parapatellar approach in TKA: muscle damage and inflammation markers. Orthopedics, 2012, 35(7): e1038-1045.
|
21. |
Feng Y, Ju H, Yang B, et al. Effects of a selective cyclooxygenase-2 inhibitor on postoperative inflammatory reaction and pain after total knee replacement. J Pain, 2008, 9(1): 45-52.
|